Therapeutic Uses (Radiotherapy, Iodine-131)
Start with the big picture
Radiotherapy can target tissue from outside the body, place sealed sources close to or within a tumor, or deliver radioactive material as a liquid therapy. The choice of isotope and delivery method depends on the target and its location. Iodine-131 concentrates in thyroid tissue through the sodium–iodide symporter. Its beta emission damages thyroid tissue, while its gamma emission can support imaging after treatment. The lesson connects these properties to its use in hyperthyroidism and differentiated thyroid cancer, and introduces contraindications, adverse effects, and radiation precautions. It also covers the role of elevated TSH in cancer ablation and post-therapy whole-body scanning. These concepts provide a framework for understanding how therapeutic radioisotopes are selected, delivered, and monitored.
What you'll learn
- Distinguish external-beam radiotherapy, brachytherapy, and targeted liquid therapy.
- Explain how iodine-131 is concentrated in thyroid tissue and delivers therapeutic radiation.
- Identify the clinical applications and key contraindications of iodine-131 therapy.
- Describe major adverse effects, radiation precautions, and post-therapy monitoring considerations.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
